Olympus Corporation (7733.T) Stock

7733.T logo

Olympus Corporation

7733.TJapan
Healthcare

Company profile

Olympus reported revenue of 997.33 billion JPY for fiscal year 2025, up 6.5% from fiscal year 2024, and net income of 117.86 billion JPY. That is a net profit margin of 11.8% for fiscal year 2025. Its largest business segment, Gastrointestinal Solutions, brought in 64% of segment revenue in fiscal year 2025; North America was the largest region with 42%. Our analysis of its filings shows revenue growing from 881.92 billion JPY in fiscal year 2023 to 997.33 billion JPY in fiscal year 2025, 6.3% a year on average. Olympus reports about 28,138 full-time employees.

What stands out

  • Net income fell 51.4% in fiscal year 2025, from 242.57 billion JPY in fiscal year 2024.
  • Revenue in fiscal year 2025 was the highest of the last 5 fiscal years.
  • It was founded in 1919.

Figures from company filings; latest fiscal year ended March 31, 2025.

About Olympus Corporation

Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, “Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.

Largest shareholders

  • Artisan Partners LP5.63%
  • Olympus Corporation4.63%
  • Baillie Gifford & Co.3.89%
  • Massachusetts Financial Services Co.3.77%
  • Sumitomo Mitsui Banking Pension Fund3.54%

Share of the company, as of September 25, 2026

Leadership

  • Robert John White — Representative Executive Officer, President, CEO & Director, 63
  • Frank Drewalowski — Senior Advisor to Chief Executive Officer, 60
  • Michael Angelo Parenti — CFO & Executive Officer, 48
  • Syed Mukarram Naveed — Executive Officer & CTO, 52
  • Gabriela Castillo Kaynor — Executive Officer, Chief Strategy Officer & ESG Officer, 50

How much revenue does Olympus make?

Olympus reported 997.33 billion JPY in revenue for fiscal year 2025, up 6.5% from 936.21 billion JPY in fiscal year 2024.

What is Olympus's largest business segment?

Gastrointestinal Solutions, with 636.30 billion JPY or 64% of segment revenue in fiscal year 2025. Next: Surgical & Interventional Solutions (36%) and Other (under 1%).

Where does Olympus make most of its revenue?

North America: 42% of revenue by region in fiscal year 2025, followed by Europe (26%).

What companies are similar to Olympus?

Listed companies of a similar size in the same industry (various healthcare equipment manufacturing) include Terumo Corporation (4543.T), Fukuda Denshi Co., Ltd. (6960.T), Nipro Corporation (8086.T), Mani, Inc. (7730.T).

Has Olympus made a profit in recent years?

Net income by fiscal year: FY2021, 12.92 billion JPY; FY2022, 115.74 billion JPY; FY2023, 143.43 billion JPY; FY2024, 242.57 billion JPY; FY2025, 117.86 billion JPY. It was profitable in each of these years.

How has Olympus' revenue changed over the last 5 fiscal years?

Revenue by fiscal year: FY2021, 730.54 billion JPY; FY2022, 750.12 billion JPY; FY2023, 881.92 billion JPY; FY2024, 936.21 billion JPY; FY2025, 997.33 billion JPY.

Company Information

SectorHealthcare
IndustryVarious Healthcare Equipment Manufacturing
Employees28,138
FoundedOct 12, 1919
IPO DateMay 16, 1949
IPO StatusPublic
HeadquartersHachioji, Japan
FoundersTakeshi Yamashita
ExchangeTokyo
TimezoneAsia/Tokyo (JST)

Contact & Links

Address
2951 Ishikawa-machi, Hachioji, 192-8507
Phone
81 42 642 2111
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Data as of .

How to cite: DataPorium, “Olympus Corporation (7733.T)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/7733.T

LinkedInLinkedInXXYouTubeYouTube